期刊文献+
共找到1,429篇文章
< 1 2 72 >
每页显示 20 50 100
Research Survey of Animal Model of Hepatic Fibro-sis Integrated with Western Medicine Diseases and Traditional Chinese Medicine^TCM~)Syndrome 被引量:1
1
作者 Peng Yue Yao Le +3 位作者 Zhao Tiejian Duan Xuelin Wei Yanfei Li Guiyu 《Animal Husbandry and Feed Science》 CAS 2017年第1期19-23,36,共6页
Although the animal models of hepatic fibrosis developed by former researchers have pathological changes of hepatic fibrosis, they do not include charac- teristics of important TCM syndromes such as stagnation of qi, ... Although the animal models of hepatic fibrosis developed by former researchers have pathological changes of hepatic fibrosis, they do not include charac- teristics of important TCM syndromes such as stagnation of qi, deficiency of qi, liver depression, phlegm-dampness and blood stasis because of single-factor model- ing. Animal models of hepatic fibrosis and animal models integrated disease and syndrome were reviewed, and several new types of integrated disease and syndrome animal models constructed by multiple-factor modeling method were evaluated, under the guidance of etiological theory of TCM. This kind of hepatic fibrosis model animals has dual characteristics of disease and syndrome. It is consistent with pathological characteristics of hepatic fibrosis in western medicine when replicating the basic characteristics accorded with TCM syndrome. Thus, the pathogenesis and pathogenic process of clinical disease and syndrome formation is simulated more ac- curately, providing a new platform and pathway for studying hepatic fibrosis disease with integrated traditional Chinese and western medicine. 展开更多
关键词 Chinese traditional medicine combination of disease and syndrome animal model
下载PDF
Study of establishing disease-syndrome combined with animal model for immune thrombocytopenic purpura without additional conditions 被引量:2
2
作者 Haiyan Lang Ming Guo +4 位作者 Yuting Chu Wei Ma Yayue Zhang Ling Zhang Xinyi Chen 《Journal of Traditional Chinese Medical Sciences》 2016年第3期135-140,共6页
Objective:To explore the feasibility of establishing the disease-syndrome combined animal model for immune thrombocytopenic purpura(ITP)without additional conditions.Methods:Three batches of data related to the ITP mo... Objective:To explore the feasibility of establishing the disease-syndrome combined animal model for immune thrombocytopenic purpura(ITP)without additional conditions.Methods:Three batches of data related to the ITP model mice obtained by replication at different time were analyzed,and whether the APS-injected model mice replicated through the passive immune modeling method could simulate the pathogenesis and clinical characteristics of human ITP was evaluated according to the differentiation criteria for diseasesyndrome combined model.Results:The APS-injected replicated ITP model mice possessed the following traits:(1)Compared with the normal group,the platelet count was significantly decreased,and coagulation time was significantly increased in the model group(P<.01).(2)Compared with the normal group,the medullary thrombocytogenous megakaryocytes were significantly decreased(P<.05,.01,.001).(3)The APS-injected sites and other parts of the model mice had spontaneous hemorrhage.(4)Behavioral changing signs were observed 1 week after the modeling(i.e.low activity,delayed activity,poor appetite,skin petechia/hemorrhage and spontaneous hemorrhage at the injected sites or other parts),and were getting more and more severe.Conclusion:According to the syndrome differentiation criteria for disease-syndrome combined model of ITP,the APS-injected animal model of ITP replicated through the passive immune modeling method without additional conditions possesses the characteristics of disease-syndrome combined model.It provides an ideal tool for the development of traditional Chinese medicine pharmacology experiment. 展开更多
关键词 Immune thrombocytopenic purpura syndrome of failure of spleen qi to control blood due to deficiency of spleen qi disease-syndrome combined animal model
下载PDF
Effects of ginsenoside of stem and leaf combined with choline on learning and memory ability of rat models with Alzheimer diseases 被引量:1
3
作者 Xiaomin Zhao Xianglin Xie +3 位作者 Zuoli Xia Yunsheng Gao Yuyun Zhu Hongxia Gu 《Neural Regeneration Research》 SCIE CAS CSCD 2006年第4期331-334,共4页
BACKGROUND: Central adrenergic nerve and 5-serotonergic nerve can influence central cholinergic nerve on learning and memory and make easy for study; however, ginsenoside of stem and leaf (GSL) can improve function... BACKGROUND: Central adrenergic nerve and 5-serotonergic nerve can influence central cholinergic nerve on learning and memory and make easy for study; however, ginsenoside of stem and leaf (GSL) can improve functions of central adrenergic nerve; moreover, 5-serotonergic nerve and the combination with choline can produce synergistic effect and enhance learning and memory ability so as to improve learning and memory disorder of patients with Alzheimer disease (AD). OBJECTIVE : To observe the effects of GSL combining with choline on learning and memory of AD model rats DESIGN : Randomized grouping design and controlled animal study SETIING : Department of Pharmacology, Taishan Medical College MATERIALS : The experiment was carried out in the Pharmacological Department of Medical College of Jilin University from October 1996 to January 1997. Forty healthy male Wistar rats of clean grade were randomly divided into 5 groups, including sham-injury group, model group, GSL group, choline group and combination group, with 8 rats in each group. Main medications: GSL with the volume more than 92.8% was provided by Department of Chemistry, Norman Bethune Medical College of Jilin University. Panaxatriol, the main component, was detected with thin layer scanning technique and regarded as the index of GSL quality [(55±1)%, CV= 2%, n = 5]. Choline was provided by the Third Shanghai Laboratory Factory. METHODS : 150 nmol quinolinic acid was used to damage bilateral Meynert basal nuclei of adult rats so as to establish AD models. Rats in GSL, choline and combination groups were intragastric administrated with 400 mg/kg GSL, 200 mg/kg choline (20 mL/kg), and both respectively last for 17 days starting from two days before operation. Rats in sham-injury group and model group were perfused with the same volume of distilled water once in each morning for the same days. (1) Passive avoidance step-down test: Five minutes later, rats jumped up safe platform when they were shocked with 36 V alternating current. If rats jumped down from the platform and the feet touched railings, the response was wrong. Numbers of wrong response were recorded within 3 minutes, and then the test was redone after 24 hours. (2) Morris water-maze spatial localization task: Swimming from jumping-off to platform directly was regarded as right response. Additionally, 4 successively right responses were regarded as the standard. Each rat was trained 10 times a day with 120 s per time for 3 successive days. The interval was 30 s. Three days later, numbers of right response were recorded. The training times were increased to 30 for unlearned rats. (3) Measurement of activity of choline acetylase in cerebral cortex: Rats were sacrificed at 17 days after operation to obtain cerebral cortex to measure activity of choline acetylase with radiochemistry technique. (4) Synergistic effect: It was expressed as Q value: Q value = factual incorporative effect/anticipant incorporative effect; Q ≥ 1 was regarded as synergistic effect. Anticipant incorporative effect = (EA+EB-EA·EB), EA and EB were single timing effect, respectively in GSL group and choline group. E(step-down test and Morris water maze test) = (x in model group - factual value in medicine groups)/x in model group; E (activity of choline acetylase) = (factual value in medicine groups -xin model group)/xin model group. MAIN OUTCOME MEASURES : (1) Passive avoidance step-down test and Morris water-maze spatial localization task in the study of learning and memory; (2) activity of choline acetylase. RESULTS : All 40 rats were involved in the final analysis. (1) Passive avoidance response: At learning phase on first day and retesting phase on the next day, numbers of wrong responses within 3 minutes were more in model group than sham operation group, and there was significant difference [(5.88±1.46), (2.25±0.87) times; (2.63±1.06), (0.50±0.53) times; P 〈 0.01]; numbers of wrong responses within 3 minutes were less in combination group than model group, and there was significant difference [learning phase: (1.12±0.83), (5.88±1.46) times; retesting phase: (0.38±0.74), (2.63±1.06)times, P 〈 0.01]; moreover, effect was stronger than that in GSL group and choline group. The Q value was 1.07 and 1.59, respectively and it showed synergistic effect. Spatial localization task: Training times were more in model group than sham operation group, and there was significant difference [(2.9±2.5), (12.6±3.5) times; P 〈 0.01]. Training times were less in combination group than model group, and there was significant difference [(11.8±2.4), (27.9±2.5) times, P 〈 0.01]; moreover, effect was stronger than that in GSL group and choline group. The Q value was 1.07 and it showed synergistic effect. (3) Activity of choline acetylase: Activity was lower in model group than sham operation group, and there was significant difference [(30.56±8.33), (61.11 ±8.33) nkat/g; P 〈 0.01]. Activity was higher in combination group than model group and there was significant difference [(50.00±8.33), (30.56±8.33) nkat/g, P 〈 0.01];moreover, effect was stronger than that in GSL group and choline group. The Q value was 1.5 and it showed synergistic effect. CONCLUSZON: GSL in combination with choline can synergically improve the disorder of learning and memory of AD model rats. Its mechanism may be involved in enhancing the function of central cholinergic system. 展开更多
关键词 stem Effects of ginsenoside of stem and leaf combined with choline on learning and memory ability of rat models with alzheimer diseases
下载PDF
Pathogenesis and drug response of iPSC-derived cardiomyocytes from two Brugada syndrome patients with different Nav1.5-subunit mutations
4
作者 Yue Zhu Linlin Wang +7 位作者 Chang Cui Huiyuan Qin Hongwu Chen Shaojie Chen Yongping Lin Hongyi Cheng Xiaohong Jiang Minglong Chen 《The Journal of Biomedical Research》 CAS CSCD 2021年第5期395-407,I0004-I0007,共17页
Brugada syndrome(BrS)is a complex genetic cardiac ion channel disease that causes a high predisposition to sudden cardiac death.Considering that its heterogeneity in clinical manifestations may result from genetic bac... Brugada syndrome(BrS)is a complex genetic cardiac ion channel disease that causes a high predisposition to sudden cardiac death.Considering that its heterogeneity in clinical manifestations may result from genetic background,the application of patient-specific induced pluripotent stem cell-derived cardiomyocytes(iPSC-CMs)may help to reveal cell phenotype characteristics underlying different genetic variations.Here,to verify and compare the pathogenicity of mutations(SCN5A c.4213G>A and SCN1B c.590C>T)identified from two BrS patients,we generated two novel BrS iPS cell lines that carried missense mutations in SCN5A or SCN1B,compared their structures and electrophysiology,and evaluated the safety of quinidine in patient-specific iPSC-derived CMs.Compared to the control group,BrS-CMs showed a significant reduction in sodium current,prolonged action potential duration,and varying degrees of decreased Vmax,but no structural difference.After applying different concentrations of quinidine,drug-induced cardiotoxicity was not observed within 3-fold unbound effective therapeutic plasma concentration(ETPC).The data presented proved that iPSC-CMs with variants in SCN5A c.4213G>A or SCN1B c.590C>T are able to recapitulate single-cell phenotype features of BrS and respond appropriately to quinidine without increasing incidence of arrhythmic events. 展开更多
关键词 human iPSCs Brugada syndrome disease modeling QUINIDINE SCN5a SCN1B
下载PDF
Visceral hypersensitivity and altered colonic motility after subsidence of inflammation in a rat model of colitis 被引量:58
5
作者 Jun-Ho La Tae-Wan Kim +3 位作者 Tae-Sik Sung Jeoung-Woo Kang Hyun-Ju Kim ⅠI-Suk Yang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2003年第12期2791-2795,共5页
AIM:Irritable bowel syndrome(IBS)is a functional bowel disorder characterized by visceral hypersensitivity and altered bowel motility.There is increasing evidence suggesting the role of inflammation in the pathogenesi... AIM:Irritable bowel syndrome(IBS)is a functional bowel disorder characterized by visceral hypersensitivity and altered bowel motility.There is increasing evidence suggesting the role of inflammation in the pathogenesis of IBS,which addresses the possibility that formerly established rat model of colitis could be used as an IBS model after the inflammation subsided. METHODS:Colitis was induced by intracolonic instillation of 4% acetic acid in male Sprague-Dawley rats.The extent of inflammation was assessed by histological examination and myeloperoxidase(MPO)activity assay.After subsidence of colitis,the rats were subjected to rectal distension and restraint stress,then the abdominal withdrawal reflex and the number of stress-induced fecal output were measured, respectively. RESULTS:At 2 days post-induction of colitis,the colon showed characteristic inflammatory changes in histology and 8-fold increase in MPO activity.At 7 days post-induction of colitis,the histological features and MPO activity returned to normal.The rats at 7 days post-induction of colitis showed hypersensitive response to rectal distension without an accompaning change in rectal compliance,and defecated more stools than control animals when under stress.CONCLUSION: These results concur largely with the characteristic features of IBS, visceral hypersensitivity and altered defecation pattern in the absence of detectable disease, suggesting that this animal model is a methodologically convenient and useful model for studying a subset of IBS. 展开更多
关键词 acetic acid animals Biological Markers COLITIS disease models animal INFLaMMaTION Irritable Bowel syndrome Male Pain PEROXIDaSE RaTS Rats Sprague-Dawley Research Support Non-U.S. Gov't
下载PDF
Animal models of pulmonary hypertension due to left heart disease 被引量:1
6
作者 Shao-Fei Liu Yi Yan 《Animal Models and Experimental Medicine》 CSCD 2022年第3期197-206,共10页
Pulmonary hypertension due to left heart disease(PH-LHD) is regarded as the most prevalent form of pulmonary hypertension(PH). Indeed, PH is an independent risk factor and predicts adverse prognosis for patients with ... Pulmonary hypertension due to left heart disease(PH-LHD) is regarded as the most prevalent form of pulmonary hypertension(PH). Indeed, PH is an independent risk factor and predicts adverse prognosis for patients with left heart disease(LHD). Clinically, there are no drugs or treatments that directly address PH-LHD, and treatment of LHD alone will not also ameliorate PH. To target the underlying physiopathological alterations of PH-LHD and to develop novel therapeutic approaches for this population, animal models that simulate the pathophysiology of PH-LHD are required. There are several available models for PH-LHD that have been successfully employed in rodents or large animals by artificially provoking an elevated pressure load on the left heart, which by transduction elicits an escalated pressure in pulmonary artery. In addition, metabolic derangement combined with aortic banding or vascular endothelial growth factor receptor antagonist is also currently applied to reproduce the phenotype of PH-LHD. As of today, none of the animal models exactly recapitulates the condition of patients with PH-LHD. Nevertheless, the selection of an appropriate animal model is essential in basic and translational studies of PH-LHD. Therefore, this review will summarize the characteristics of each PH-LHD animal model and discuss the advantages and limitations of the different models. 展开更多
关键词 animal model l eft ventricular failure metabolic syndrome pulmonary hypertension due to left heart disease pulmonary vascular remodeling
下载PDF
Forecasting Alzheimer’s Disease Using Combination Model Based on Machine Learning
7
作者 He Li Yuhang Wu +2 位作者 Yingnan Zhang Tao Wei Yufeng Gui 《Applied Mathematics》 2018年第4期403-417,共15页
As the acceleration of aged population tendency, building models to forecast Alzheimer’s Disease (AD) is essential. In this article, we surveyed 1157 interviewees. By analyzing the results using three machine learnin... As the acceleration of aged population tendency, building models to forecast Alzheimer’s Disease (AD) is essential. In this article, we surveyed 1157 interviewees. By analyzing the results using three machine learning methods—BP neural network, SVM and random forest, we can derive the accuracy of them in forecasting AD, so that we can compare the methods in solving AD prediction. Among them, random forest is the most accurate method. Moreover, to combine the advantages of the methods, we build a new combination forecasting model based on the three machine learning models, which is proved more accurate than the models singly. At last, we give the conclusion of the connection between life style and AD, and provide several suggestions for elderly people to help them prevent AD. 展开更多
关键词 alzheimer’s disease BP NEURaL Network SVM RandOM FOREST combination Forecasting model
下载PDF
Update on establishment of TCM animal model of myocardial ischemia and Chinese medicine treatment
8
作者 Yu-Fei Feng Gui-Xin He +5 位作者 Yong-Yan Shen Wei-Bin Qin Ting Xiao Li-Yan Yu Meng-Xian Hu Guo-Kun Zheng 《Journal of Hainan Medical University》 2022年第7期76-76,共1页
The prevention and treatment of myocardial ischemia is a hot and difficult point in clinical research and animal experimental research in the cardiovascular field.The combined disease and syndrome animal model with th... The prevention and treatment of myocardial ischemia is a hot and difficult point in clinical research and animal experimental research in the cardiovascular field.The combined disease and syndrome animal model with the disease characteristics of Western medicine and guided by the theory of Chinese medicineto replicate the"syndrome"of Chinese medicine on the model animals by using experimental methods is an effective tool for the research of Chinese medicine.This article summarized the methoding methods and evaluation index of the animal model combined disease of coronary heart disease myocardial ischemia with cold blood stasis,phlegm and blood stasis,qi deficiency and blood stasis syndrome,kidney deficiency and blood stasis,and concluded the treatment of Traditional Chinese medicine.At the same time,it analyzed the main deficiencies of myocardial ischemia syndrome combined with animal models to provide reference for the establishment and research of related animal models. 展开更多
关键词 Myocardial ischemia animal model disease combination Traditional Chinese Medicine
下载PDF
基于hACE2转导建立SARS-CoV-2 spike假病毒感染病证结合的小鼠病毒肺炎模型
9
作者 邱敏 陈欢 +2 位作者 江飞龙 朱青 刘莉 《中国中医急症》 2024年第9期1553-1556,1565,共5页
目的建立与评价一种安全、经济、有效的病证结合小鼠新冠病毒感染肺炎模型。方法30只KM种小鼠随机分为空白组、对照组及实验1组、实验2组、实验3组,每组各6只。每天把KM小鼠置于模拟寒湿环境中4 h,将表达hACE2的重组腺相关病毒(pAAV-hAC... 目的建立与评价一种安全、经济、有效的病证结合小鼠新冠病毒感染肺炎模型。方法30只KM种小鼠随机分为空白组、对照组及实验1组、实验2组、实验3组,每组各6只。每天把KM小鼠置于模拟寒湿环境中4 h,将表达hACE2的重组腺相关病毒(pAAV-hACE2)采用改良悬挂法气管内给药转导至肺组织,继以新型冠状病毒(SARS-CoV-2)spike假病毒采用相同的气管内给药方式造模。观察各组小鼠一般情况,检测体重变化、肺指数、血清炎性因子及肺部病理变化。结果免疫组化法显示h ACE2在小鼠肺组织中有效表达;在寒湿环境中给予SARS-CoV-2 spike假病毒后,实验组小鼠表现出类似疫毒犯肺证候的体征;且同样喂养条件和时间下,与空白组和对照组小鼠比较,实验组小鼠出现体重下降;实验1、2、3组小鼠出现肺指数显著增大(P<0.05或P<0.01),血清炎性因子白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、肿瘤坏死因子-α(TNF-α)显著升高(P<0.01),肺组织病理改变明显。结论本研究成功建立了一种安全、经济、有效的病证结合小鼠新冠病毒感染肺炎模型。 展开更多
关键词 新型冠状病毒(SaRS-CoV-2)spike假病毒 重组腺相关病毒(paaV-haCE2) 寒湿疫 病证结合 病毒 肺炎 小鼠动物模型
下载PDF
基于《伤寒论》的六经辨证体系中医辨证模型推荐处方与临床医生处方结果的Kappa一致性分析
10
作者 何德英 陈勇 +1 位作者 南瑞雪 任毅 《临床医学研究与实践》 2024年第5期96-99,共4页
目的分析基于《伤寒论》的六经辨证体系中医辨证模型推荐处方与临床医生处方结果的一致性。方法纳入门诊患者共747例,医生通过四诊的采集得出治疗处方,再以手机终端录入采集的相关症状、体征后得到系统推荐处方。利用Kappa一致性检验来... 目的分析基于《伤寒论》的六经辨证体系中医辨证模型推荐处方与临床医生处方结果的一致性。方法纳入门诊患者共747例,医生通过四诊的采集得出治疗处方,再以手机终端录入采集的相关症状、体征后得到系统推荐处方。利用Kappa一致性检验来评价基于《伤寒论》的六经辨证体系中医辨证模型推荐处方与临床医生处方结果的一致性。结果基于《伤寒论》的六经辨证体系中医辨证模型推荐处方与临床医生处方的结果具有高度一致性,差异具有统计学意义(Kappa=0.71,P<0.001)。结论基于《伤寒论》的六经辨证体系中医辨证模型推荐处方与临床医生处方结果具有一致性,可辅助临床医生处方。 展开更多
关键词 《伤寒论》 六经辨证体系 中医辨证模型 一致性
下载PDF
基于多中心的老年OSAHS合并冠心病患者不良预后的Nomogram预测模型构建
11
作者 韩静 诸雯 蒋菲 《临床和实验医学杂志》 2024年第5期462-465,共4页
目的基于多中心分析老年阻塞性睡眠呼吸暂停低通气综合征(OSAHS)合并冠心病患者不良预后的影响因素并构建Nomogram预测模型。方法于2020年3月至2022年3月选取江苏省中医院共357例老年OSAHS合并冠心病患者,按照7∶3比例将纳入患者分为建... 目的基于多中心分析老年阻塞性睡眠呼吸暂停低通气综合征(OSAHS)合并冠心病患者不良预后的影响因素并构建Nomogram预测模型。方法于2020年3月至2022年3月选取江苏省中医院共357例老年OSAHS合并冠心病患者,按照7∶3比例将纳入患者分为建模组(n=250)及验证组(n=107)。对患者进行为期1年的随访,根据患者预后将建模组分为预后良好组(n=215)和预后不良组(n=35)。单因素及多因素Logistic回归分析影响老年OSAHS合并冠心病患者不良预后的因素,并根据此结果构建Nomogram预测模型,再以H-L拟合度曲线评估模型的有效性,以受试者工作特征(ROC)曲线评估模型的区分度。结果单因素分析结果显示,体重指数、睡眠呼吸暂停低通气指数(AHI)、睡眠平均氧饱和度(SaO_(2))、超敏C反应蛋白(hs-CRP)及白细胞介素-6(IL-6)为老年OSAHS合并冠心病患者不良预后的影响因素(P<0.05)。多因素Logistic回归分析显示,体重指数较高、AHI水平较高、hs-CRP水平较高、低水平的睡眠平均SaO_(2)为老年OSAHS合并冠心病患者不良预后的影响因素(P<0.05)。验证模型显示,建模组χ^(2)=6.125,P=0.421,ROC曲线下面积AUC为0.958(95%CI:0.926~0.980),敏感度及特异度分别为82.86%、96.28%;验证组χ^(2)=5.754,P=0.311,AUC为0.932(95%CI:0.893~0.960),敏感度及特异度分别为85.70%、88.40%。结论体重指数较高、AHI水平较高、hs-CRP水平较高、低水平的睡眠平均SaO_(2)为老年OSAHS合并冠心病患者不良预后的影响因素,以此构建的Nomogram预测模型具有较好的区分度及有效性,可帮助临床预测患者不良预后的发生风险,具有较高的临床价值。 展开更多
关键词 老年 阻塞性睡眠呼吸暂停低通气综合征 冠心病 Nomogram预测模型 影响因素 不良预后
下载PDF
Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease 被引量:3
12
作者 Zhiyong Shi Lingyun Wu +3 位作者 Yi Wang Huasheng Zhang Yongbo Yang Chunhua Hang 《Chinese Neurosurgical Journal》 CAS CSCD 2023年第3期190-198,共9页
Background To investigate the incidence,risk factors,and clinical prognosis of cerebral hyperperfusion syndrome(CHS)after superficial temporal artery-middle cerebral artery anastomosis combined with encephalo-duro-art... Background To investigate the incidence,risk factors,and clinical prognosis of cerebral hyperperfusion syndrome(CHS)after superficial temporal artery-middle cerebral artery anastomosis combined with encephalo-duro-arterio-synangiosis(STA-MCA/EDAS)in adult patients with moyamoya disease(MMD).Methods The clinical data of 160 adult patients with MMD treated by STA-MCA/EDAS from January 2016 to January 2017 were retrospectively analyzed.According to CHS diagnosis,MMD patients were divided into CHS and non-CHS group.Univariate and multivariate analysis of risk factors and Kaplan-Meier curve of stroke-free survival for CHS were performed.Results A total of 12 patients(7.5%)developed postoperative CHS,of which 4 patients(2.5%)presented with cerebral hemorrhage.Univariate and multivariate analysis showed moyamoya vessel on the surgical hemisphere(OR=3.04,95%CI=1.02-9.03,P=0.046)and left operated hemisphere(OR=5.16,95%CI=1.09-21.34,P=0.041)were independent risk factors for CHS.The other variables,such as age,gender,presentation,hypertension,diabetes,smoking,mean mRS score on admission,modified Suzuki stage and pre-infarction stage on surgical hemisphere,and bypass patency,had no association with postoperative CHS(P>0.05).At final follow-up with average 38 months,there were 18 out of 133 patients(13.5%,4.91%per person year)presented with newly developed complications.There was no significant difference between newly developed complications,mean mRS scores,and Kaplan-Meier curve of stroke-free survival in patients with and without CHS(P>0.05).Conclusion The concentration of moyamoya vessels and left operated hemisphere was independent risk factors for CHS,which could not affect the clinical prognosis if treated timely and properly.The current study offers a new perspective of moyamoya vessels and supporting data for choosing MMD candidates on cerebral revascularization. 展开更多
关键词 Moyamoya disease Combined cerebral revascularization Cerebral hyperperfusion syndrome Risk factors Clinical prognosis
原文传递
基于SARIMA-LSTM模型的肾综合征出血热发病率预测研究
13
作者 唐诗诗 李宇轩 +2 位作者 唐圣晟 刘庆华 周毅 《医学信息学杂志》 CAS 2024年第8期71-77,共7页
目的/意义探究前沿技术在肾综合征出血热发病率预测中的应用,梳理、组合多种时序分析方法,评价并筛选最佳模型。方法/过程利用2004—2020年全国肾综合征出血热发病率数据,基于统计学方法的SARIMA、STL-ARIMA、TBATS模型,基于神经网络的N... 目的/意义探究前沿技术在肾综合征出血热发病率预测中的应用,梳理、组合多种时序分析方法,评价并筛选最佳模型。方法/过程利用2004—2020年全国肾综合征出血热发病率数据,基于统计学方法的SARIMA、STL-ARIMA、TBATS模型,基于神经网络的NNAR、LSTM模型,基于3种加权方式的SARIMA-LSTM组合模型进行预测,运用RMSE、MAE、MAPE综合评价模型效果。结果/结论SARIMA、LSTM在单一模型中较优;SARIMA-LSTM组合模型效果相较单一模型均有提升;基于误差倒数法的SARIMA-LSTM组合模型为最优模型。本研究有望为肾综合征出血热发病预警系统模型设计提供技术支持与参考。 展开更多
关键词 肾综合征出血热 传染病监测预警 统计学模型 机器学习 SaRIMa-LSTM模型
下载PDF
血清CC16、sRAGE水平与ARDS患者疾病转归的相关性及预测价值研究
14
作者 张伟 王辉 张中兴 《现代医药卫生》 2024年第5期809-813,共5页
目的 探讨血清Clara细胞分泌蛋白16(CC16)、可溶性晚期糖基化终产物受体(sRAGE)水平变化与急性呼吸窘迫综合征(ARDS)患者疾病转归的相关性及预测价值。方法 选取2021年1月至2023年1月灵宝市第二人民医院收治的127例ARDS患者为研究对象,... 目的 探讨血清Clara细胞分泌蛋白16(CC16)、可溶性晚期糖基化终产物受体(sRAGE)水平变化与急性呼吸窘迫综合征(ARDS)患者疾病转归的相关性及预测价值。方法 选取2021年1月至2023年1月灵宝市第二人民医院收治的127例ARDS患者为研究对象,根据ARDS严重程度将患者分为轻度组(39例)、中度组(52例)和重度组(36例)。比较不同严重程度患者及不同疾病转归患者血清CC16、sRAGE水平、氧合指数(PaO_(2)/FiO_(2))、急性生理学及慢性健康状况Ⅱ(APACHEⅡ)评分、序贯器官衰竭评估(SOFA)评分,分析血清CC16、sRAGE水平与PaO_(2)/FiO_(2)、APACHEⅡ评分、SOFA评分及疾病转归的相关性。采用logistic回归分析ARDS患者病死的危险因素,受试者工作特征(ROC)曲线分析血清CC16、sRAGE水平及二者联合检测对ARDS患者病死的预测价值。结果 ARDS不同程度患者入院时血清CC16、sRAGE水平及APACHEⅡ、SOFA评分比较:轻度组<中度组<重度组,PaO_(2)/FiO_(2)比较:轻度组>中度组>重度组,差异均有统计学意义(P<0.05);病死患者入院时血清CC16、sRAGE水平及APACHEⅡ、SOFA评分均高于生存患者,而PaO_(2)/FiO_(2)低于生存患者,差异均有统计学意义(P<0.05);患者入院时血清CC16、sRAGE水平与PaO_(2)/FiO_(2)均呈负相关(P<0.05),与APACHEⅡ、SOFA评分及疾病转归均呈正相关(P<0.05);入院时血清CC16、sRAGE水平为ARDS患者病死的危险因素,且两指标联合预测ARDS患者病死的ROC曲线下面积大于各单项指标(P<0.05)。结论 ARDS患者血清CC16、sRAGE表达上调,其水平与疾病转归密切相关,二者联合检测可作为临床早期预测转归情况的有效指标。 展开更多
关键词 血清Clara细胞分泌蛋白16 可溶性晚期糖基化终产物受体 急性呼吸窘迫综合征 疾病转归 联合检测 预测
下载PDF
基于“互联网+”的认知康复训练在老年脑小血管病伴OSAHS认知障碍患者中的应用研究
15
作者 马美晨 李向华 +3 位作者 陈玉 白亚芳 田晓静 田三胜 《老年医学与保健》 CAS 2024年第5期1333-1337,共5页
目的研究通过分析“互联网+”模式下的认知康复训练在老年脑小血管病(CSVD)伴阻塞性呼吸暂停低通气综合征(OSAHS)认知障碍患者的疗效,以期为临床患者的院外干预提供方法。方法回顾性选择2022年1月—2023年6月在沧州市人民医院接受治疗的... 目的研究通过分析“互联网+”模式下的认知康复训练在老年脑小血管病(CSVD)伴阻塞性呼吸暂停低通气综合征(OSAHS)认知障碍患者的疗效,以期为临床患者的院外干预提供方法。方法回顾性选择2022年1月—2023年6月在沧州市人民医院接受治疗的120例老年CSVD合并OSAHS认知障碍患者,依据患者不同的干预方式分为观察组和对照组,每组60例。对照组采取常规的护理干预,观察组在对照组的基础上应用“互联网+”模式下的认知康复训练。观察并比较2组干预前后认知功能、生活能力等变化。结果干预3个月后,2组患者MoCA量表、MMSE量表、ADL量表评分均高于同组干预前(P<0.05),且观察组MoCA量表、MMSE量表、ADL量表评分均高于对照组(P<0.05);2组患者CysC、Hcy水平均低于同组干预前(P<0.05),但2组间差异均无统计学意义(P>0.05)。结论“互联网+”模式下的认知康复训练对老年CSVD合并OSAHS认知障碍患者效果显著,可提高患者的认知功能与生活自理能力,具有一定的临床应用价值。 展开更多
关键词 老年 脑小血管病 阻塞性呼吸暂停低通气综合征 “互联网+”模式 认知功能 认知障碍 生活自理能力
下载PDF
The efficacy of TKIs in treatment of human primary small cell lung cancer xenograft model in vivo
16
作者 Yu-hua ZHaNG Liang SUN +1 位作者 Bin LIU Guo-qiang LI 《中国应用生理学杂志》 CAS CSCD 2016年第6期525-528,共4页
Objective: To study the treatmaient of non-small cell lung cancer, we established the HU-Prim allograft transplantation tumor model. Methods: The fresh tumor samples were transplanted in the right scapular subcutaneou... Objective: To study the treatmaient of non-small cell lung cancer, we established the HU-Prim allograft transplantation tumor model. Methods: The fresh tumor samples were transplanted in the right scapular subcutaneous layer of the severe combined immunodeficient Non-obese diabetic/severe combined immunodeficient(NOD/SCID) mice. The pathological features of the tumors were observed. Nonnecrotic tissue was inoculated subcutaneously into the right axillary. When the tumor in burdened rat grew approximately 100 mm3, according to the tumor size all the animals were divided into the following four groups, eight rats in each group: solvent control group, gefitinib group(100 mg/kg), erlotinib group(50 mg/kg), afatinib group(20 mg/kg). Aniamals were treated with drugs by intragastric(i.g.) administrated, once daily, for consecutively 14 days. Measure the tumor size 2-3 times every week. Results: Hu Prime1-NSCLC mutant sensitive xenograft model research data showed that reversible tyrosine kinase inhibitors gefitinib, erlotinib and irreversible tyrosine kinase inhibitor afatinib could effectively inhibit tumor growth in EGFR positive NSCLC allografts model. The pharmacodynamic activity of irreversible inhibitor was better than that of the reversible inhibitor. Specimens from clinical anthropogenic tumor retain characteristics of the human primary malignancy, histopathology, biological characteristics, and tumor markers, etc., which can more accurately reflect the characteristics of the tumor and the impact of interventions. Conclusion: The model is not only a good antitumor drug experimental platform, but also a new evaluation tool of individualized medication. 展开更多
关键词 非小细胞肺癌 肿瘤模型 异种移植 药物治疗 酪氨酸激酶抑制剂 人类 原发性 组织病理学
下载PDF
Clinical treatment of myasthenia gravis with deficiency of spleen and kidney based on combination of disease with syndrome theory 被引量:6
17
作者 Chao Jiang Ping Liu +3 位作者 Yan Liang Shaobo Qiu Wenjing Bao Jingsheng Zhang 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2013年第4期444-448,共5页
OBJECTIVE: To study the use of Jianjining in the treatment of myasthenia gravis (MG) patients with a deficiency of both spleen and kidney via the theory on the combination of disease with syndrome. METHODS: Sixty MG p... OBJECTIVE: To study the use of Jianjining in the treatment of myasthenia gravis (MG) patients with a deficiency of both spleen and kidney via the theory on the combination of disease with syndrome. METHODS: Sixty MG patients with a deficiency of both spleen and kidney were randomly divided into an treatment group (n=30) treated with Jianjining granules and Western Medicine (prednisone or pyridostigmine bromide) and a control group (n= 30) treated with Jianjining granules. The dosage of the three drugs was reduced over the course of treatment. After 3 and 6 months of treatment, the curative effect was evaluated with the muscle weakness severity scale (MWSS). RESULTS: The MWSS score after treatment declined significantly in both groups. The score in the treatment group was much lower than that in thecontrol group (P<0.05). The total effective rate was 63.33% (19/30) in the treatment group and 36.67% (11/30) in the control group after 3 months of treatment, and 80.00% (24/30) and 50.00% (15/30), respectively, after 6 months of treatment. The obvious and total effective rates in the treatment group were much higher than those in the control group (P<0.05). After 6 months of treatment, there were no obvious differences (P>0.05) in the obvious and effective rates between the 2 groups. However, the total effective rate in the treatment group was much higher than that in the control group (P<0.01). CONCLUSION: Using the theory on the combination of disease with syndrome, we found that the curative effect of Jianjining and Western Medicine on MG patients with deficiency of both spleen and kidney is worth further exploration. 展开更多
关键词 Myasthenia gravis Deficiency of spleen and kidney Jianjining combination of disease with syndrome
原文传递
基于综合任务模型探索HIV/AIDS患者的疾病适应过程和体验
18
作者 肖雪玲 李怡轩 +1 位作者 苏昕怡 王红红 《中南大学学报(医学版)》 CAS CSCD 北大核心 2023年第6期887-894,共8页
目的:艾滋病毒/艾滋病(human immunodeficiency virus/acquired immunodeficiency syndrome,HIV/AIDS)患者在疾病适应过程中面临着诸多困难。本研究基于综合任务模型,深入阐释该人群与HIV共存的疾病适应过程和体验,以及该过程中患者面... 目的:艾滋病毒/艾滋病(human immunodeficiency virus/acquired immunodeficiency syndrome,HIV/AIDS)患者在疾病适应过程中面临着诸多困难。本研究基于综合任务模型,深入阐释该人群与HIV共存的疾病适应过程和体验,以及该过程中患者面临的适应任务,为促进该人群的疾病适应提供参考。方法:采用诠释现象学设计,使用目的抽样选取研究对象,在43例HIV/AIDS患者中开展半结构式访谈,采用Van Manen的资料分析法分析数据。结果:最终提取意义单元1307个,形成主题6个,副主题14个;其中,HIV/AIDS患者的疾病适应过程总结为“阳光之下,阴影相加”,适应任务方面表现为心理锚定的方向、身体任务管理、社会网络与支持、就业益处和困境、关于未来的考虑等。结论:HIV/AIDS患者的疾病适应过程是共性化和个性化特征并存的,构建干预策略时需要关注适应任务的相互影响和整体性,促进共性和个性问题的解决,从而助力该人群获得良好的适应结局。 展开更多
关键词 HIV/aIDS患者 综合任务模型 现象学研究 疾病适应
下载PDF
Gemtuzumab ozogamicin in the treatment of adult acute myeloid leukemia 被引量:1
19
作者 Hiroko Tsunemine Takayuki Takahashi 《Health》 2013年第5期8-16,共9页
Gemtuzumab ozogamicin (GO) is a humanized anti-CD33 monoclonal antibody conjugated to a derivative of an antitumor antibiotic, calicheamicin. GO was approved for the treatment of relapsed acute myeloid leukemia (AML) ... Gemtuzumab ozogamicin (GO) is a humanized anti-CD33 monoclonal antibody conjugated to a derivative of an antitumor antibiotic, calicheamicin. GO was approved for the treatment of relapsed acute myeloid leukemia (AML) in the United States (US) in 2000. However, GO was withdrawn from the US market in June 2010, because a large-scale clinical trial failed to show additive or synergistic effects with conventional chemotherapy for newly diagnosed AML. GO is currently available only in Japan. However, several large clinical studies have demonstrated beneficial effects of GO when added to chemotherapy for AML in recent years;therefore, reconsideration of GO availability is gaining attention. Therefore, the role and efficacy of GO as monotherapy or in combination therapy for de novo or relapsed AML should be positively investigated. 展开更多
关键词 GEMTUZUMaB Ozogamicin aCUTE MYELOID LEUKEMIa aCUTE PROMYELOCYTIC LEUKEMIa MONOTHERaPY combination Chemotherapy Sinusoidal Obstruction syndrome Veno-Occlusive disease
下载PDF
Disease-Syndrome Combination Clinical Study of Psoriasis:Present Status,Advantages,and Prospects 被引量:5
20
作者 卢传坚 喻靖杰 邓静文 《Chinese Journal of Integrative Medicine》 SCIE CAS 2012年第3期166-171,共6页
Psoriasis is an immune-abnormal,chronic,proliferative skin disease determined by polygenic inheritance and induced by a number of environmental factors.It causes worldwide concern because of its high-prevalence,harmfu... Psoriasis is an immune-abnormal,chronic,proliferative skin disease determined by polygenic inheritance and induced by a number of environmental factors.It causes worldwide concern because of its high-prevalence,harmful and incurable characteristics.Over the years,Chinese medicine(CM) treatment of psoriasis has accumulated a wealth of clinical experience.Disease-syndrome combination, which achieves more satisfactory clinical effect,is the basis to highlight the special CM advantages in treating psoriasis.In this paper,we review the advantages of treating psoriasis with the combination of disease and syndrome,analyze the prospects of research on treating psoriasis combining disease with syndrome.We also make a point that there are several key points for the clinical research of combination of disease and syndrome.It can be expected that carrying out clinical research on the combination of disease and syndrome will help improve the clinical efficacy of medical treatment of psoriasis,which will be the main direction of research in the future. 展开更多
关键词 PSORIaSIS disease-syndrome combination Chinese medicine complementary and alternative medicine herbal medicine
原文传递
上一页 1 2 72 下一页 到第
使用帮助 返回顶部